The present invention relates to a pharmaceutical composition for oral administration comprising a GLP receptor agonist or pharmaceutically acceptable salt or derivatives thereof, one or more medium chain fatty acid based permeation enhancers with aromatic functional group, and one or more medium chain fatty acid based permeation enhancers without aromatic functional group. The pharmaceutical composition may optionally further comprise a basifier.